Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents

In patients with stable coronary artery disease or low-risk ACS treated with zotarolimus-eluting stents, 3 months of dual antiplatelet therapy was noninferior to 12 months for NACCE, without significantly increasing the risk of stent thrombosis.

http://jama.jamanetwork.com/article.aspx?articleid=1765224

%d bloggers like this: